Birchview Capital »

Cullinan Oncology shares owned by Birchview Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Birchview Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $244k 20k 12.18
2024-09-30 $335k 20k 16.74
2024-06-30 $349k 20k 17.44
2024-03-31 $428k 25k 17.04
2023-12-31 $256k 25k 10.19
2023-09-30 $227k 25k 9.05
2023-06-30 $270k 25k 10.76
2023-03-31 $257k 25k 10.23
2022-12-31 $265k 25k 10.55
2022-09-30 $322k 25k 12.82
2022-06-30 $578k 45k 12.81
2022-03-31 $472k 45k 10.46
2021-12-31 $696k 45k 15.43
2021-09-30 $1.0M 45k 22.57
2021-06-30 $1.2M 45k 25.76
2021-03-31 $2.5M 60k 41.67